PCM
NTUS

Penn Capital Management’s Natus Medical Inc NTUS Stock Holding History

Penn Capital Management’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-45,163
Closed -$1.16M – 230
2021
Q1 		$1.16M Sell
45,163
-24,752
-35% -$635K 0.12% 162
2020
Q4 		$1.4M Buy
+69,915
New +$1.37M 0.18% 142
2017
Q1 		– Sell
-87,931
Closed -$3.53M – 301
2016
Q4 		$3.53M Sell
87,931
-218,449
-71% -$8.58M 0.22% 137
2016
Q3 		$12M Buy
306,380
+43,255
+16% +$1.73M 0.82% 36
2016
Q2 		$9.98M Buy
+263,125
New +$8.81M 0.57% 65
2014
Q2 		– Sell
-73,146
Closed -$1.89M – 298
2014
Q1 		$1.89M Sell
73,146
-129,288
-64% -$3.26M 0.07% 227
2013
Q4 		$4.55M Sell
202,434
-147,323
-42% -$2.85M 0.16% 160
2013
Q3 		$4.96M Buy
349,757
+41,970
+14% +$561K 0.21% 161
2013
Q2 		$4.2M Buy
+307,787
New +$4.19M 0.17% 180

Other funds holding NTUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Penn Capital Management's NTUS Position: Q2 2021 in Review

Penn Capital Management sold out of Natus Medical Inc (NTUS) in Q2 2021, closing a stake of 45,163 shares — an estimated $1.16M sold.

Penn Capital Management first reported a position in NTUS in Q2 2013 and held it in 9 quarters. The position peaked at $12M in Q3 2016. 170 funds tracked by Wall St. Rank hold NTUS as of Q2 2021.

  • Penn Capital Management reported no remaining Natus Medical Inc position as of Q2 2021 after selling out during the quarter.
  • Penn Capital Management sold 45,163 Natus Medical Inc shares in Q2 2021, an estimated $1.16M.
  • Penn Capital Management first reported a position in Natus Medical Inc in Q2 2013 and held it in 9 quarters.
  • Penn Capital Management's Natus Medical Inc position peaked at $12M in Q3 2016.
  • 170 funds tracked by Wall St. Rank held Natus Medical Inc as of Q2 2021.

Based on Penn Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.